DMXE Pellets – 40mg
€ 16,00 – € 72,50Price range: € 16,00 through € 72,50
DMXE Pellets 40mg are described as compressed laboratory research pellets with a nominal label claim of 40 mg deoxymethoxetamine per unit.
DMXE, also known as 3D-MXE, is a dissociative arylcyclohexylamine structurally related to methoxetamine.
The source identifies the material as a hydrochloride salt and provides CAS number 2666932-45-0.
However, the supplied molecular formula C15H22N2O·HCl and molecular weight 282.81 g/mol are inconsistent with the stated chemical name.
These specifications require correction before publication.
The product brief reports typical ingredient purity of at least 98%, third-party analytical verification, batch traceability, and ISO-compliant manufacturing conditions.
No batch-specific Certificate of Analysis, finished-pellet assay, content-uniformity dataset, or manufacturing certification was supplied.
The nominal 40 mg label claim therefore does not establish verified ingredient content in each pellet.
DMXE belongs to a psychoactive dissociative chemical class, and its toxicological profile remains incompletely characterized.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
DMXE Pellets 40mg – Research Material Information
DMXE Pellets 40mg – Product Overview
The supplied product is described as compressed research pellets containing deoxymethoxetamine, also known as DMXE or 3D-MXE.
Each pellet carries a nominal label claim of 40 mg.
The source identifies the material as a hydrochloride salt and describes laboratory contexts involving chemical characterization, chromatographic analysis, and spectroscopic identification.
No finished-pellet assay or independent content-uniformity report was supplied.
The stated content is therefore a nominal specification rather than a verified measurement for each unit.
The source also contains molecular identity discrepancies that should be resolved before definitive publication.
Chemical Identity & Classification
DMXE belongs to the arylcyclohexylamine chemical class and is structurally related to methoxetamine.
The source describes it as a derivative in which the methoxy group of methoxetamine is replaced by a methyl group.
The supplied chemical specifications are:
- Compound: Deoxymethoxetamine
- Abbreviations: DMXE, 3D-MXE
- Supplied chemical name: 2-(Ethylamino)-2-(3-methylphenyl)cyclohexan-1-one hydrochloride
- Reported CAS number: 2666932-45-0
- Supplied molecular formula: C15H22N2O·HCl
- Supplied molecular weight: 282.81 g/mol
- Chemical class: Arylcyclohexylamine
- Product form: Compressed pellets
- Nominal content: 40 mg per pellet
The supplied chemical name describes a compound containing one nitrogen atom.
The reported formula contains two nitrogen atoms and is therefore inconsistent with that name.
The named neutral structure corresponds to C15H21NO, with a molecular weight of approximately 231.34 g/mol.
Its corresponding hydrochloride composition is C15H22ClNO, with a molecular weight of approximately 267.80 g/mol.
The supplied CAS assignment and actual salt form should be verified against authoritative records and batch-specific identity evidence.
Public chemical-reference information can be reviewed through PubChem.
Chemical & Physical Characteristics
The source describes a compressed pellet presentation.
No independently verified pellet dimensions, color specifications, excipient composition, hardness measurements, or disintegration data were supplied.
The brief refers to physicochemical characterization and analytical separation behavior.
These properties may depend on the chemical form, formulation ingredients, and physical characteristics of the finished pellet.
No validated dissolution, solubility, or quantitative-recovery dataset was provided.
The consistency of pellet appearance or total mass does not establish uniform active-ingredient content.
Purity & Analytical Verification
The source reports typical ingredient purity of at least 98%.
It also claims independent laboratory verification of chemical identity and purity.
No chromatograms, mass spectra, NMR spectra, impurity profiles, or batch-specific Certificate of Analysis were supplied.
The reported purity remains unverified.
The brief identifies HPLC, GC-MS, LC-MS, and NMR spectroscopy as relevant analytical techniques.
These methods can provide complementary evidence concerning chemical composition and structure.
However, no validated method-performance data or certified quantitative reference values were supplied.
Ingredient purity and finished-pellet content are separate measurements.
A high-purity starting material does not establish that every compressed pellet contains exactly 40 mg of the reported compound.
Quality Control & Batch Integrity
The source claims full batch traceability, independent analytical testing, and content-uniformity verification.
It also reports manufacturing under ISO-compliant conditions.
No manufacturing certification, accreditation record, batch-traceability report, or independent analytical documentation was supplied.
The phrase “ISO-compliant” does not identify a specific standard or demonstrate certification.
The stated availability of a third-party Certificate of Analysis upon request does not establish that a particular batch has been independently verified.
These quality-control statements should be treated as unverified supplier claims.
Safety, Handling & Laboratory Precautions
DMXE belongs to a dissociative psychoactive chemical class.
Its toxicological profile remains incompletely characterized.
Potential concerns associated with dissociative arylcyclohexylamines include impaired coordination, confusion, altered perception, agitation, and cardiovascular complications.
Institutional safety procedures should address restricted access, suitable protective equipment, contamination prevention, accidental-exposure response, secure custody, and appropriate waste management.
No verified product-specific Safety Data Sheet was supplied.
The pellet format does not establish suitability for human or veterinary administration.
Packaging, Labeling & Storage
The source describes compressed pellets supplied in child-resistant containers.
It recommends storage in a cool, dry environment protected from light, with a suggested temperature range of approximately 2–8°C.
No validated product-specific stability study was supplied to establish this temperature as necessary or sufficient.
No verified shelf life, container-performance specification, or finished-product stability dataset was provided.
Product labels should accurately distinguish nominal content, chemical form, and independently verified batch specifications.
Intended Research Use & Market Positioning
The source identifies analytical laboratory contexts involving arylcyclohexylamine characterization, chromatographic profiling, spectroscopic identification, and forensic chemical analysis.
No certified reference-material status or validated quantitative calibration performance has been established.
The supplied Raw Lab Chems catalog references are:
These references concern related but chemically distinct arylcyclohexylamines.
They should not be represented as interchangeable compounds or analytically equivalent materials.
Ordering, Availability & Fulfillment
The source claims worldwide shipping, tracking, protective packaging, and regulatory compliance.
No current inventory record, carrier authorization, transport classification, or supporting shipping documentation was supplied.
These claims cannot be independently confirmed.
Research-only labeling does not automatically exempt a psychoactive substance from controlled-substance legislation, analogue laws, or import restrictions.
Transport eligibility and legal authorization depend on the applicable jurisdiction and transaction.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
DMXE is a psychoactive arylcyclohexylamine-related substance that may be subject to controlled-substance, analogue, chemical-safety, import, or export restrictions.
Institutions are responsible for verifying applicable legal requirements and maintaining appropriate authorization, laboratory controls, and secure custody.
No therapeutic approval, consumer-use authorization, or certified reference-material status is implied.
The chemical identity, molecular formula, molecular weight, and salt form should be reconciled before publication as definitive specifications.
| Quantity (pellets) |
5 ,10 ,25 |
|---|
You must be logged in to post a review.

Reviews
There are no reviews yet.